7 Buffalo Funds Named to IBD Best Mutual Funds 2021 List

7 Buffalo Funds Named to IBD Best Mutual Funds 2021 List

Media Coverage

7 Buffalo Funds Named to IBD Best Mutual Funds 2021 List

Overview

The Buffalo Funds recently had seven funds selected for the Investor’s Business Daily 2021 Best Mutual Funds Award Winner list, in the 6th annual ranking by the investment publication.

Best U.S. Diversified

  • Buffalo Early Stage Growth Fund
  • Buffalo Small Cap Fund
  • Buffalo Discovery Fund
  • Buffalo Large Cap Fund
  • Buffalo Growth Fund

Best Large Cap

  • Buffalo Large Cap Fund
  • Buffalo Growth Fund

Best Mid Cap

  • Buffalo Discovery Fund

Best Small Cap

  • Buffalo Early Stage Growth Fund
  • Buffalo Small Cap Fund

Best International

  • Buffalo International Fund

Best U.S. Taxable Bond

  • Buffalo High Yield Fund

Funds named to IBD’s list were chosen because they have outperformed their benchmark index over the past 1, 3, 5, and 10-year periods, as of 12/31/20. In order to make the list, funds must have outperformed in all four time periods. IBD made its selections from 3,368 mutual funds that met the criteria of having at least 10 years of operation.

We’re honored that our funds have been recognized in this way by IBD. These funds exemplify our firm’s goal of consistently delivering strong risk-adjusted performance to our shareholders, said Kent Gasaway, president of the Buffalo Funds.

To view IBD’s complete list and analysis of the Best Mutual Funds 2021, please visit: https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-beating-sp-500-over-last-1-3-5-10-years/

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed may be worth more or less than their original value. Current performance may be lower or higher than the performance quoted. Performance data current to the most recent month-end may be obtained here. Performance data current to the most recent quarter-end may be obtained here. Performance is annualized for periods greater than 1 year.

Opinions expressed are those of the author or Funds and are subject to change, are not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

References to other mutual funds should not to be considered an offer to buy or sell these securities.

HIGHLIGHT

Seven Buffalo Funds were named to Investor’s Business Daily Best Mutual Funds 2021 list, including the Best U.S. Diversified, Growth, Large Cap, Mid Cap, Small Cap, International, and U.S. Taxable Bond Fund categories.

MEDIA CONTACT

Joel Crampton
Director of Marketing
(913) 647-9881
Email

Sign Up for Automatic Updates

Stay up-to-date with the most recent media coverage and press releases about the Buffalo Funds.

FOR FINANCIAL PROFESSIONALS

Terms of Use – Email lists are created for use by U.S. investment professionals only and are published strictly for informational purposes. Providing access to the content of these emails does not explicitly or implicitly constitute a solicitation of services or products of the Buffalo Funds, Kornitzer Capital Management, or any of their affiliates. The information contained in the emails is not intended for distribution to, or for use by, investment professionals in a jurisdiction where distribution or purchase is not authorized. The information contained in these emails is not appropriate for use by individual investors. By registering for any of these emails, you agree to Buffalo's terms and conditions and that you are qualified as an institutional investor or otherwise member of a registered broker/dealer, registered investment advisor, or investment consulting firm.

FOR INDIVIDUAL INVESTORS

“Money Life Market Call” with Buffalo Discovery Fund PM Ken Laudan

“Money Life Market Call” with Buffalo Discovery Fund PM Ken Laudan

Media Coverage

“Money Life Market Call” with Buffalo Discovery Fund PM Ken Laudan

Overview

Buffalo Discovery Fund co-portfolio manager Ken Laudan recently appeared on the “Money Life with Chuck Jaffe” podcast.

During the call, Ken goes in-depth on healthcare investing and provides an overview of his investment methodology. He also covers the current state of the healthcare companies developing the COVID-19 vaccines. Ken also provides thoughts on the following companies:

  • Avantor (NYSE: AVTR)
  • Hologic (NASDAQ: HOLX)
  • Pfizer (NYSE: PFE)
  • AstraZeneca (NASDAQ: AZN)
  • Merck (NYSE: MRK)
  • BioMarin Pharmaceuticals (NASDAQ: BMRN)
  • Centene (NYSE: CNC)
  • Seagen (NASDAQ: SGEN)
  • Bristol-Myers Squibb (NYSE: BMY)

Going from a vaccine discovery point in March to a commercial product in December is stunning; whether that is replicable post COVID I’m dubious, but it’s certainly a positive thing because I just don’t think we’ll have the type of accommodating FDA that we had seen with respect to the vaccine.

~ Ken Laudan, Co-Portfolio Manager, Buffalo Discovery Fund

MORE ABOUT KEN


Ken Laudan
Portfolio Manager
27 Years of Experience
 View full bio

Opinions expressed are those of the author or Funds as of 12/4/20 and are subject to change, are not intended to be a forecast of future events, a guarantee of future results, nor investment advice. References to other mutual funds should not to be considered an offer to buy or sell these securities. A full listing of the Buffalo Discovery Fund portfolio holdings can be found here. Past performance does not guarantee future results. Earnings growth is not representative of the Fund’s future performance. Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company’s profitability. The S&P 500 is a capitalization weighted index of 500 large capitalization stocks which is designed to measure broad domestic securities markets. The S&P Biotechnology Select Industry Index represents the biotechnology segment of the S&P Total Market Index, which is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the Biotechnology sub-industry. One cannot invest directly in an index. Free cash flow is a measure of the cash produced by the firm in a given period on behalf of equity holders. The true measure of the value of a firm’s equity is considered to be the present value of all free cash flows.

Sign Up for Automatic Updates

Stay up-to-date with the most recent media coverage and press releases about the Buffalo Funds.

FOR FINANCIAL PROFESSIONALS

Terms of Use – Email lists are created for use by U.S. investment professionals only and are published strictly for informational purposes. Providing access to the content of these emails does not explicitly or implicitly constitute a solicitation of services or products of the Buffalo Funds, Kornitzer Capital Management, or any of their affiliates. The information contained in the emails is not intended for distribution to, or for use by, investment professionals in a jurisdiction where distribution or purchase is not authorized. The information contained in these emails is not appropriate for use by individual investors. By registering for any of these emails, you agree to Buffalo's terms and conditions and that you are qualified as an institutional investor or otherwise member of a registered broker/dealer, registered investment advisor, or investment consulting firm.

FOR INDIVIDUAL INVESTORS